149 related articles for article (PubMed ID: 19340854)
1. Body mass index predicts insulin resistance in survivors of pediatric acute lymphoblastic leukemia.
Lowas S; Malempati S; Marks D
Pediatr Blood Cancer; 2009 Jul; 53(1):58-63. PubMed ID: 19340854
[TBL] [Abstract][Full Text] [Related]
2. Association between body mass index and insulin resistance in survivors of pediatric acute lymphoblastic leukemia.
Bahoush G; Salajegheh P; Rohani F
Leuk Res Rep; 2020; 13():100199. PubMed ID: 32346509
[TBL] [Abstract][Full Text] [Related]
3. Hyperglycemia during induction therapy for acute lymphoblastic leukemia is temporally linked to pegaspargase administration.
Pollock NI; Flamand Y; Zhu J; Millington K; Stevenson K; Silverman LB; Vrooman LM; Cohen LE
Pediatr Blood Cancer; 2022 Jul; 69(7):e29505. PubMed ID: 34931744
[TBL] [Abstract][Full Text] [Related]
4. Obesity and insulin resistance in pediatric acute lymphoblastic leukemia worsens during maintenance therapy.
Esbenshade AJ; Simmons JH; Koyama T; Lindell RB; Friedman DL
Pediatr Blood Cancer; 2013 Aug; 60(8):1287-91. PubMed ID: 23444342
[TBL] [Abstract][Full Text] [Related]
5. Screening for asymptomatic diabetes and metabolic comorbidities in pediatric patients during therapy for acute lymphoblastic leukemia.
Larouche V; Bellavance C; Tibout P; Bergeron S; Simonyan D; Gagné J
J Pediatr Endocrinol Metab; 2021 May; 34(5):627-632. PubMed ID: 33838097
[TBL] [Abstract][Full Text] [Related]
6. Assessment of insulin sensitivity from measurements in fasting state and during an oral glucose tolerance test in obese children.
Atabek ME; Pirgon O
J Pediatr Endocrinol Metab; 2007 Feb; 20(2):187-95. PubMed ID: 17396435
[TBL] [Abstract][Full Text] [Related]
7. Transient hyperglycemia in Hispanic children with acute lymphoblastic leukemia.
Baillargeon J; Langevin AM; Mullins J; Ferry RJ; DeAngulo G; Thomas PJ; Estrada J; Pitney A; Pollock BH
Pediatr Blood Cancer; 2005 Dec; 45(7):960-3. PubMed ID: 15700246
[TBL] [Abstract][Full Text] [Related]
8. Medication-induced diabetes during induction treatment for ALL, an early marker for future metabolic risk?
Yeshayahu Y; Koltin D; Hamilton J; Nathan PC; Urbach S
Pediatr Diabetes; 2015 Mar; 16(2):104-8. PubMed ID: 24673941
[TBL] [Abstract][Full Text] [Related]
9. Screening survivors of childhood acute lymphoblastic leukemia for obesity, metabolic syndrome, and insulin resistance.
Karakurt H; Sarper N; Kılıç SÇ; Gelen SA; Zengin E
Pediatr Hematol Oncol; 2012 Sep; 29(6):551-61. PubMed ID: 22897748
[TBL] [Abstract][Full Text] [Related]
10. Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia.
Tonorezos ES; Vega GL; Sklar CA; Chou JF; Moskowitz CS; Mo Q; Church TS; Ross R; Janiszewski PM; Oeffinger KC
Pediatr Blood Cancer; 2012 Jan; 58(1):31-6. PubMed ID: 21254377
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of transient hyperglycemia during induction chemotherapy for pediatric acute lymphoblastic leukemia.
Lowas SR; Marks D; Malempati S
Pediatr Blood Cancer; 2009 Jul; 52(7):814-8. PubMed ID: 19260096
[TBL] [Abstract][Full Text] [Related]
12. Body composition in young adult survivors of childhood acute lymphoblastic leukaemia.
Jarfelt M; Lannering B; Bosaeus I; Johannsson G; Bjarnason R
Eur J Endocrinol; 2005 Jul; 153(1):81-9. PubMed ID: 15994749
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of prediabetes in a Swedish cohort of severely obese children.
Ek AE; Rössner SM; Hagman E; Marcus C
Pediatr Diabetes; 2015 Mar; 16(2):117-28. PubMed ID: 24635861
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome in children and adolescents with acute lymphoblastic leukemia after the completion of chemotherapy.
Kourti M; Tragiannidis A; Makedou A; Papageorgiou T; Rousso I; Athanassiadou F
J Pediatr Hematol Oncol; 2005 Sep; 27(9):499-501. PubMed ID: 16189445
[TBL] [Abstract][Full Text] [Related]
15. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
16. Obesity and metabolic syndrome in adolescent survivors of standard risk childhood acute lymphoblastic leukemia in Saudi Arabia.
Aldhafiri F; Al-Nasser A; Al-Sugair A; Al-Mutairi H; Young D; Reilly JJ
Pediatr Blood Cancer; 2012 Jul; 59(1):133-7. PubMed ID: 22162511
[TBL] [Abstract][Full Text] [Related]
17. Assessment of metabolic syndrome parameters in pediatric acute lymphoblastic leukemia survivors.
Kartal Ö; Gürsel O
Indian J Cancer; 2023; 60(3):325-330. PubMed ID: 36861687
[TBL] [Abstract][Full Text] [Related]
18. Survivors of standard risk acute lymphoblastic leukemia do not have increased risk for overweight and obesity compared to non-cancer peers: a report from the Children's Oncology Group.
Lindemulder SJ; Stork LC; Bostrom B; Lu X; Devidas M; Hunger S; Neglia JP; Kadan-Lottick NS
Pediatr Blood Cancer; 2015 Jun; 62(6):1035-41. PubMed ID: 25663378
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of soluble tumor necrosis factor-alpha receptor 2 are linked to insulin resistance and glucose intolerance in children.
Gupta A; Ten S; Anhalt H
J Pediatr Endocrinol Metab; 2005 Jan; 18(1):75-82. PubMed ID: 15679072
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia.
Oeffinger KC; Adams-Huet B; Victor RG; Church TS; Snell PG; Dunn AL; Eshelman-Kent DA; Ross R; Janiszewski PM; Turoff AJ; Brooks S; Vega GL
J Clin Oncol; 2009 Aug; 27(22):3698-704. PubMed ID: 19564534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
